✦ LIBER ✦

P164 - Clinical pharmacology of vedolizumab (MLN0002) in patients with active ulcerative colitis

✍ Scribed by C. Scholz; T. Wyant; T. Leach; S. Sankoh; D.R. Mould; M. Patella; A. Parikh; I. Fox; L. von Moltke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P235 Long-term clinical experience with

✍ A. Parikh; T. Leach; J. Xu; B. Feagan 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

P385 Population pharmacokinetic modellin

✍ Rosario, M.; Dirks, N.; Gastonguay, M.; Fox, I.; Milton, A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 64 KB

Mo1225 Population Pharmacokinetic Modeli

✍ Dirks, Nathanael L.; Rosario, Maria; Gastonguay, Marc R.; Fox, Irving; Milton, A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 124 KB

DOP076 Improvements in health-related qu

✍ Feagan, B.; Colombel, J.-F.; Rubin, D.; Mody, R.; Sankoh, S.; Lasch, K. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 164 KB

Mo1672 Clinical Implications of Endoscop

✍ Feagins, Linda A.; Melton, Shelby D.; Iqbal, Ramiz; Dunbar, Kerry B.; Spechler, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

P398 Clinical course of ulcerative colit

✍ E. Toader; R. Lidia; C. Liliana 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 50 KB